These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22732368)

  • 1. Special issue on steroids and cancer. Preface.
    Geisler J; Sasano H
    J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):67. PubMed ID: 22732368
    [No Abstract]   [Full Text] [Related]  

  • 2. Current topics and perspectives in the treatment of endocrine-related cancers.
    Iwase H
    Int J Clin Oncol; 2008 Oct; 13(5):377-9. PubMed ID: 18946746
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
    Bodmer A; Castiglione-Gertsch M
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985
    [No Abstract]   [Full Text] [Related]  

  • 4. Information Concerning Endocrine Therapy and Adherence of Patients with Breast and Prostate Cancer.
    Linke B; Liebl P; Marten D; Stoll C; Jung B; Wuensch P; Huebner J
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):482-3. PubMed ID: 25869258
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
    Nicholson RI; Walker KJ; Davies P
    Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormones and antihormones, cancer of the breast and prostate, escape and treatment].
    André J
    Ann Endocrinol (Paris); 2003 Oct; 64(4):350-1. PubMed ID: 14595252
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy is antihormonal therapy--how much proof do oncologists need?
    Jordan VC
    Eur J Cancer; 1998 Apr; 34(5):606-8. PubMed ID: 9713262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Frequent errors in hormone treatment of neoplasms].
    Martz G
    Ther Umsch; 1969 Jul; 26(7):402-7. PubMed ID: 5801185
    [No Abstract]   [Full Text] [Related]  

  • 9. Goserelin.
    Nurs Times; 2006 Jan 17-23; 102(3):41. PubMed ID: 16440976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism and side effect of endocrine therapy].
    Tsuda M; Ishiguro H; Saji S
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():291-7. PubMed ID: 25831770
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of endocrine therapy.
    Pritchard KI; Sutherland DJ
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):765-805. PubMed ID: 2481670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The present position of hormone treatment of metastasizing cancer diseases].
    Martz G
    Praxis; 1967 Nov; 56(48):1625-9. PubMed ID: 5632548
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational tool-kit on diet and exercise: survey of prostate cancer patients about to receive androgen deprivation therapy.
    Lebret T; Coloby P; Descotes JL; Droupy S; Geraud M; Tombal B
    Urology; 2010 Dec; 76(6):1434-9. PubMed ID: 21130255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
    Boudreaux KJ; Chang SS
    BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of the hormone sensitivity of prostate cancer: where are we now?
    Alcaraz A
    Eur Urol; 2008 Aug; 54(2):247-50; discussion 250-1. PubMed ID: 18343562
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral sensitivity to steroids revisited.
    Hampl R; Vondra K
    Physiol Res; 2017 Sep; 66(Suppl 3):S295-S303. PubMed ID: 28948813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of bone metastases].
    Tubiana-Hulin M
    Bull Cancer Radiother; 1996; 83(4):299-304. PubMed ID: 9081331
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.